Uveitis in HIV positive patients.
Cunningham
E T
ET
D000998:Antiviral Agents / Q000009:adverse effects / Q000627:therapeutic use; D000077404:Cidofovir; D003586:Cytomegalovirus Infections / Q000150:complications; D003596:Cytosine / Q000009:adverse effects / Q000031:analogs & derivatives; D006679:HIV Seropositivity / Q000150:complications* / Q000188:drug therapy; D006801:Humans; D063065:Organophosphonates; D009943:Organophosphorus Compounds / Q000009:adverse effects; D017828:Rifabutin / Q000009:adverse effects; D012507:Sarcoidosis / Q000150:complications; D013587:Syphilis / Q000150:complications; D014376:Tuberculosis / Q000150:complications; D014605:Uveitis / Q000139:chemically induced / Q000188:drug therapy / Q000821:virology*
D000998:Antiviral Agents; D063065:Organophosphonates; D009943:Organophosphorus Compounds; D017828:Rifabutin; D003596:Cytosine; D000077404:Cidofovir